SG/CALL/FRESENIUS MEDICAL CARE/42/0.1/20.12.24 Stock

Warrant

DE000SQ72WV2

Delayed Deutsche Boerse AG 07:21:58 2024-07-01 EDT
0.13 EUR 0.00% Intraday chart for SG/CALL/FRESENIUS MEDICAL CARE/42/0.1/20.12.24
Current month-59.38%
1 month-60.61%
Date Price Change
24-07-01 0.13 0.00%
24-06-28 0.13 -7.14%
24-06-27 0.14 0.00%
24-06-26 0.14 0.00%
24-06-25 0.14 -12.50%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 07:21 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Société Générale Société Générale
WKN SQ72WV
ISINDE000SQ72WV2
Date issued 2023-01-18
Strike 42
Maturity 2024-12-20 (172 Days)
Parity 10 : 1
Emission price 0.39
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.26
Lowest since issue 0.13
Spread 0.01
Spread %6.67%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.76 EUR
Average target price
39.97 EUR
Spread / Average Target
+11.78%
Consensus